This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Westall, F. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Westall, F. C.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, June 2006, p. 2099-2104, Vol. 44, No. 6
0095-1137/06/$08.00+0     doi:10.1128/JCM.02532-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Molecular Mimicry Revisited: Gut Bacteria and Multiple Sclerosis

Fred C. Westall*

Institute for Disease Research, P.O. Box 890193, Temecula, California 92589

Received 5 December 2005/ Accepted 5 April 2006

Molecular mimicry is a possible explanation for autoimmune side effects of microorganism infections. Protein sequences from a particular microorganism are compared to known autoimmune immunogens. For diseases such as multiple sclerosis (MS), where the infectious agent is unknown, guesses to its identity are made. Mimics are assumed to be rare. This study takes a radically different approach. Reported sequences from all known human bacterial and viral agents were searched for autoimmune immunogen mimics. Three encephalitogenic peptides, whose autoimmune requirements have been studied extensively, were selected for comparison. Mimics were seen in a wide variety of organisms. For each immunogen, the mimics were found predominantly in nonpathogenic gut bacteria. Since the three immunogens used in this study are related to MS, it is suggested that a microorganism responsible for autoimmune activity in MS could be a normally occurring gut bacterium. This would explain many of the peculiar MS epidemiological data and why no infective agent has been identified for MS and supports recently found MS gut metabolism abnormalities.

* Mailing address: Institute for Disease Research, P.O. Box 890193, Temecula, CA 92589. Phone: (951) 699-5177. Fax: (951) 699-5177. E-mail: fcwestallidr{at}adelphia.net.

Journal of Clinical Microbiology, June 2006, p. 2099-2104, Vol. 44, No. 6
0095-1137/06/$08.00+0     doi:10.1128/JCM.02532-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»